Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.

Marins LMS, Torres TS, Leite IDC, Moreira RI, Luz PM, Hoagland B, Kallas EG, Madruga JV, Liu AY, Anderson PL, Grinsztejn B, Veloso VG.

PLoS One. 2019 Aug 20;14(8):e0221281. doi: 10.1371/journal.pone.0221281. eCollection 2019.

2.

An Internet-Based HIV Self-Testing Program to Increase HIV Testing Uptake Among Men Who Have Sex With Men in Brazil: Descriptive Cross-Sectional Analysis.

De Boni RB, Veloso VG, Fernandes NM, Lessa F, Corrêa RG, Lima RS, Cruz M, Oliveira J, Nogueira SM, de Jesus B, Reis T, Lentini N, Miranda RL, Bingham T, Johnson CC, Barbosa Junior A, Grinsztejn B.

J Med Internet Res. 2019 Aug 1;21(8):e14145. doi: 10.2196/14145.

3.

Authorship Correction: Factors Associated With Willingness to Use Pre-Exposure Prophylaxis in Brazil, Mexico, and Peru: Web-Based Survey Among Men Who Have Sex With Men.

Torres TS, Konda KA, Vega-Ramirez EH, Elorreaga OA, Diaz-Sosa D, Hoagland B, Diaz S, Pimenta C, Benedetti M, Lopez-Gatell H, Robles-Garcia R, Grinsztejn B, Caceres C, Veloso VG; ImPrEP Study Group.

JMIR Public Health Surveill. 2019 Jul 18;5(3):e15504. doi: 10.2196/15504.

4.

A case report of HIV-1 superinfection in an HIV controller leading to loss of viremia control: a retrospective of 10 years of follow-up.

Caetano DG, Côrtes FH, Bello G, de Azevedo SSD, Hoagland B, Villela LM, Grinsztejn B, Veloso VG, Guimarães ML, Morgado MG.

BMC Infect Dis. 2019 Jul 5;19(1):588. doi: 10.1186/s12879-019-4229-3.

5.

The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention.

Luz PM, Veloso VG, Grinsztejn B.

Curr Opin HIV AIDS. 2019 Sep;14(5):366-373. doi: 10.1097/COH.0000000000000564.

6.

Factors Associated With Willingness to Use Pre-Exposure Prophylaxis in Brazil, Mexico, and Peru: Web-Based Survey Among Men Who Have Sex With Men.

Torres TS, Konda KA, Vega-Ramirez EH, Elorreaga OA, Diaz-Sosa D, Hoagland B, Diaz S, Pimenta C, Bennedeti M, Lopez-Gatell H, Robles-Garcia R, Grinsztejn B, Caceres C, Veloso VG; ImPrEP Study Group.

JMIR Public Health Surveill. 2019 Jun 17;5(2):e13771. doi: 10.2196/13771. Erratum in: JMIR Public Health Surveill. 2019 Jul 18;5(3):e15504.

7.

Factors associated with PrEP awareness according to age and willingness to use HIV prevention technologies: the 2017 online survey among MSM in Brazil.

Torres TS, Luz PM, De Boni RB, de Vasconcellos MTL, Hoagland B, Garner A, Moreira RI, Veloso VG, Grinsztejn B.

AIDS Care. 2019 Oct;31(10):1193-1202. doi: 10.1080/09540121.2019.1619665. Epub 2019 May 23.

PMID:
31122033
8.

Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.

Spinelli MA, Glidden DV, Anderson PL, Gandhi M, McMahan VM, Defechereux P, Schechter M, Veloso VG, Chariyalertsak S, Guanira JV, Bekker LG, Buchbinder SP, Grant RM.

AIDS Res Hum Retroviruses. 2019 Sep;35(9):788-793. doi: 10.1089/AID.2018.0297. Epub 2019 Jun 19.

PMID:
31119944
9.

Effectiveness of direct-acting agents for hepatitis C and liver stiffness changing after sustained virological response.

Fernandes FF, Piedade J, Guimaraes L, Nunes EP, Chaves U, Goldenzon RV, Cardoso SW, Duarte J, Grinsztejn B, Veloso VG, Pereira G, Perazzo H.

J Gastroenterol Hepatol. 2019 May 7. doi: 10.1111/jgh.14707. [Epub ahead of print]

PMID:
31062880
10.

Proviral Quasispecies Diversity Is Not Associated With Virologic Breakthrough or CD4+ T Cell Loss in HIV-1 Elite Controllers.

de Azevedo SSD, Côrtes FH, Delatorre E, Ribeiro-Alves M, Hoagland B, Grinsztejn B, Veloso VG, Morgado MG, Bello G.

Front Microbiol. 2019 Apr 2;10:673. doi: 10.3389/fmicb.2019.00673. eCollection 2019.

11.

Transcendendo: A Cohort Study of HIV-Infected and Uninfected Transgender Women in Rio de Janeiro, Brazil.

Ferreira ACG, Coelho LE, Jalil EM, Luz PM, Friedman RK, Guimarães MRC, Moreira RC, Eksterman LF, Cardoso SW, Castro CV, Derrico M, Moreira RI, Fernandes B, Monteiro L, Kamel L, Pacheco AG, Veloso VG, Grinsztejn B.

Transgend Health. 2019 Apr 5;4(1):107-117. doi: 10.1089/trgh.2018.0063. eCollection 2019.

12.

Reduction of HIV-1 Reservoir Size and Diversity After 1 Year of cART Among Brazilian Individuals Starting Treatment During Early Stages of Acute Infection.

Leite TF, Delatorre E, Côrtes FH, Ferreira ACG, Cardoso SW, Grinsztejn B, de Andrade MM, Veloso VG, Morgado MG, Guimarães ML.

Front Microbiol. 2019 Feb 11;10:145. doi: 10.3389/fmicb.2019.00145. eCollection 2019.

13.

The Intersection of HIV, Social Vulnerability, and Reproductive Health: Analysis of Women Living with HIV in Rio de Janeiro, Brazil from 1996 to 2016.

Zachek CM, Coelho LE, Domingues RMSM, Clark JL, De Boni RB, Luz PM, Friedman RK, de Andrade ÂCV, Veloso VG, Lake JE, Grinsztejn B.

AIDS Behav. 2019 Jun;23(6):1541-1551. doi: 10.1007/s10461-019-02395-x.

PMID:
30652206
14.

Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection.

de Paula HHS, Ferreira ACG, Caetano DG, Delatorre E, Teixeira SLM, Coelho LE, João EG, de Andrade MM, Cardoso SW, Grinsztejn B, Veloso VG, Morgado MG, Guimarães ML, Côrtes FH.

Retrovirology. 2018 Dec 12;15(1):76. doi: 10.1186/s12977-018-0458-6.

15.

HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection.

de Azevedo SSD, Delatorre E, Côrtes FH, Hoagland B, Grinsztejn B, Veloso VG, Souza TML, Morgado MG, Bello G.

AIDS. 2019 Mar 1;33(3):399-410. doi: 10.1097/QAD.0000000000002090.

PMID:
30531316
16.

Health-related quality of life assessment among people living with HIV in Rio de Janeiro, Brazil: a cross-sectional study.

Castro R, De Boni RB, Luz PM, Velasque L, Lopes LV, Medina-Lara A, Cardoso SW, De Oliveira MS, Friedman RK, Grinsztejn B, Veloso VG.

Qual Life Res. 2019 Apr;28(4):1035-1045. doi: 10.1007/s11136-018-2044-8. Epub 2018 Nov 10.

PMID:
30415417
17.

Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy.

Perazzo H, Cardoso SW, Yanavich C, Nunes EP, Morata M, Gorni N, da Silva PS, Cardoso C, Almeida C, Luz P, Veloso VG, Grinsztejn B.

J Int AIDS Soc. 2018 Nov;21(11):e25201. doi: 10.1002/jia2.25201.

18.

Congenital Cytomegalovirus and HIV Perinatal Transmission.

Adachi K, Xu J, Ank B, Watts DH, Camarca M, Mofenson LM, Pilotto JH, Joao E, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Machado DM, Ceriotto M, Morgado MG, Bryson YJ, Veloso VG, Grinsztejn B, Mirochnick M, Moye J, Nielsen-Saines K; MPH for the NICHD HPTN 040 Study Team.

Pediatr Infect Dis J. 2018 Oct;37(10):1016-1021. doi: 10.1097/INF.0000000000001975.

PMID:
30216294
19.

Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.

Caetano DG, Côrtes FH, Bello G, Teixeira SLM, Hoagland B, Grinsztejn B, Veloso VG, Guimarães ML, Morgado MG.

Retrovirology. 2018 Sep 10;15(1):62. doi: 10.1186/s12977-018-0444-z.

20.

Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil.

Jalil EM, Grinsztejn B, Velasque L, Ramos Makkeda A, Luz PM, Moreira RI, Kamel L, Fernandes NM, Ferreira ACG, Hoagland B, Wagner S, Liu A, McFarland W, Buchbinder S, Veloso VG, Wilson E; for Transcender Study Team.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):445-452. doi: 10.1097/QAI.0000000000001839.

PMID:
30142140
21.

Accuracy of quick sequential organ failure assessment score to predict mortality in hospitalized patients with suspected infection in an HIV/AIDS reference centre in Rio de Janeiro, Brazil.

Moreira J, Paixão A, Oliveira J, Jaló W, Manuel O, Rodrigues R, Oliveira A, Tinoco L, Lima J, Grinsztejn B, Veloso VG, Japiassú AM, Lamas CC.

Clin Microbiol Infect. 2019 Jan;25(1):113.e1-113.e3. doi: 10.1016/j.cmi.2018.08.003. Epub 2018 Aug 15.

PMID:
30118761
22.

Early Retention in Care Neither Mediates Nor Modifies the Effect of Sex and Sexual Mode of HIV Acquisition on HIV Survival in the Americas.

Coelho L, Rebeiro PF, Castilho JL, Caro-Vega Y, Mejia FA, Cesar C, Cortes CP, Padgett D, McGowan CC, Veloso VG, Sterling TR, Grinsztejn B, Shepherd BE, Luz PM.

AIDS Patient Care STDS. 2018 Aug;32(8):306-313. doi: 10.1089/apc.2018.0028. Erratum in: AIDS Patient Care STDS. 2018 Sep 1;32(9):379.

23.

Plasmatic Levels of IL-18, IP-10, and Activated CD8+ T Cells Are Potential Biomarkers to Identify HIV-1 Elite Controllers With a True Functional Cure Profile.

Côrtes FH, de Paula HHS, Bello G, Ribeiro-Alves M, de Azevedo SSD, Caetano DG, Teixeira SLM, Hoagland B, Grinsztejn B, Veloso VG, Guimarães ML, Morgado MG.

Front Immunol. 2018 Jul 11;9:1576. doi: 10.3389/fimmu.2018.01576. eCollection 2018.

24.

Self-testing, communication and information technology to promote HIV diagnosis among young gay and other men who have sex with men (MSM) in Brazil.

De Boni RB, Lentini N, Santelli AC, Barbosa A Jr, Cruz M, Bingham T, Cota V, Correa RG, Veloso VG, Grinsztejn B.

J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25116. doi: 10.1002/jia2.25116. No abstract available.

25.

Zika Virus Infection and Differential Diagnosis in a Cohort of HIV-Infected Patients.

Calvet GA, Brasil P, Siqueira AM, Zogbi HE, de Santis Gonçalves B, da Silva Santos A, Lupi O, Valls de Souza R, Damasceno Dos Santos Rodrigues C, da Silveira Bressan C, Wakimoto MD, Saraiva de Araújo E, Cardoso Dos Santos I, Georg I, Ribeiro Nogueira RM, Veloso VG, Bispo de Filippis AM.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):237-243. doi: 10.1097/QAI.0000000000001777.

PMID:
29912006
26.

Cost-effectiveness of diagnostic and therapeutic interventions for chronic hepatitis C: a systematic review of model-based analyses.

Castro R, Crathorne L, Perazzo H, Silva J, Cooper C, Varley-Campbell J, Marinho DS, Haasova M, Veloso VG, Anderson R, Hyde C.

BMC Med Res Methodol. 2018 Jun 13;18(1):53. doi: 10.1186/s12874-018-0515-9.

27.

PrEP adopted by the brazilian national health system: What is the size of the demand?

Luz PM, Benzaken A, Alencar TM, Pimenta C, Veloso VG, Grinsztejn B.

Medicine (Baltimore). 2018 May;97(1S Suppl 1):S75-S77. doi: 10.1097/MD.0000000000010602.

28.

Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors.

Bakal DR, Coelho LE, Luz PM, Clark JL, De Boni RB, Cardoso SW, Veloso VG, Lake JE, Grinsztejn B.

J Antimicrob Chemother. 2018 Aug 1;73(8):2177-2185. doi: 10.1093/jac/dky145.

29.

The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.

Luz PM, Osher B, Grinsztejn B, Maclean RL, Losina E, Stern ME, Struchiner CJ, Parker RA, Freedberg KA, Mesquita F, Walensky RP, Veloso VG, Paltiel AD.

J Int AIDS Soc. 2018 Mar;21(3):e25096. doi: 10.1002/jia2.25096.

30.

Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.

Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga JV, Goulart S, Leite IC, Freitas L, Martins LMS, Torres TS, Vasconcelos R, De Boni RB, Anderson PL, Liu A, Luz PM, Veloso VG; PrEP Brasil Study Team.

Lancet HIV. 2018 Mar;5(3):e136-e145. doi: 10.1016/S2352-3018(18)30008-0. Epub 2018 Feb 18.

PMID:
29467098
31.

Syndemics among individuals enrolled in the PrEP Brasil Study.

De Boni RB, Machado IK, De Vasconcellos MTL, Hoagland B, Kallas EG, Madruga JV, Fernandes NM, Cerqueira NB, Moreira RI, Goulart SP, Veloso VG, Grinsztejn B, Luz PM.

Drug Alcohol Depend. 2018 Apr 1;185:168-172. doi: 10.1016/j.drugalcdep.2017.12.016. Epub 2018 Feb 10.

PMID:
29454927
32.

Awareness of Prevention Strategies and Willingness to Use Preexposure Prophylaxis in Brazilian Men Who Have Sex With Men Using Apps for Sexual Encounters: Online Cross-Sectional Study.

Torres TS, De Boni RB, de Vasconcellos MT, Luz PM, Hoagland B, Moreira RI, Veloso VG, Grinsztejn B.

JMIR Public Health Surveill. 2018 Jan 22;4(1):e11. doi: 10.2196/publichealth.8997.

33.

Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission.

Adachi K, Xu J, Yeganeh N, Camarca M, Morgado MG, Watts DH, Mofenson LM, Veloso VG, Pilotto JH, Joao E, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado DM, Bryson YJ, Grinsztejn B, Moye J, Klausner JD, Bristow CC, Dickover R, Mirochnick M, Nielsen-Saines K; NICHD HPTN 040 Study Team.

PLoS One. 2018 Jan 5;13(1):e0189851. doi: 10.1371/journal.pone.0189851. eCollection 2018.

34.

Human Immunodeficiency Virus Antiretroviral Resistance and Transmission in Mother-Infant Pairs Enrolled in a Large Perinatal Study.

Yeganeh N, Kerin T, Ank B, Watts DH, Camarca M, Joao EC, Pilotto JH, Veloso VG, Bryson Y, Gray G, Theron G, Dickover R, Morgado MG, Santos B, Kreitchmann R, Mofenson L, Nielsen-Saines K.

Clin Infect Dis. 2018 May 17;66(11):1770-1777. doi: 10.1093/cid/cix1104.

35.

Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil.

Moreira J, Castro R, Lamas C, Ribeiro S, Grinsztejn B, Veloso VG.

Int J Infect Dis. 2018 Apr;69:11-19. doi: 10.1016/j.ijid.2017.12.014. Epub 2017 Dec 15.

36.

Hybrid capture as a tool for cervical lesions screening in HIV-infected women: insights from a Brazilian cohort.

Jalil EM, Luz PM, Quintana M, Friedman RK, Madeira RMDS, Andrade AC, Chicarino J, Moreira RI, Derrico M, Levi JE, Russomano F, Veloso VG, Grinsztejn B.

Braz J Infect Dis. 2018 Jan - Feb;22(1):16-23. doi: 10.1016/j.bjid.2017.10.007. Epub 2017 Dec 6.

37.

Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.

Perazzo H, Jorge MJ, Silva JC, Avellar AM, Silva PS, Romero C, Veloso VG, Mujica-Mota R, Anderson R, Hyde C, Castro R.

BMC Gastroenterol. 2017 Nov 23;17(1):119. doi: 10.1186/s12876-017-0676-8. Review.

38.

Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach.

Oliveira RVC, Shimakura SE, Campos DP, Hökerberg YHM, Victoriano FP, Ribeiro S, Veloso VG, Grinsztejn B, Carvalho MS.

AIDS Care. 2018 May;30(5):551-559. doi: 10.1080/09540121.2017.1391984. Epub 2017 Oct 23.

PMID:
29058481
39.

HIV testing and the care continuum among transgender women: population estimates from Rio de Janeiro, Brazil.

Jalil EM, Wilson EC, Luz PM, Velasque L, Moreira RI, Castro CV, Monteiro L, Garcia ACF, Cardoso SW, Coelho LE, McFarland W, Liu AY, Veloso VG, Buchbinder S, Grinsztejn B.

J Int AIDS Soc. 2017 Sep 19;20(1):21873. doi: 10.7448/IAS.20.1.21873. Erratum in: J Int AIDS Soc. 2018 Jan 22;21(1):e25047.

40.

Age-standardized mortality rates related to viral hepatitis in Brazil.

Perazzo H, Pacheco AG, Luz PM, Castro R, Hyde C, Fittipaldi J, Rigolon C, Cardoso SW, Grinsztejn B, Veloso VG.

BMC Infect Dis. 2017 Jul 31;17(1):527. doi: 10.1186/s12879-017-2619-y.

41.

Towards an ideal antiretroviral regimen for the global HIV epidemic.

Grinsztejn B, Coelho LE, Luz PM, Veloso VG.

J Virus Erad. 2017 Jul 1;3(3):111-116.

42.

Asymptomatic anorectal Chlamydia trachomatis and Neisseria gonorrhoeae infections are associated with systemic CD8+ T-cell activation.

Vieira VA, Avelino-Silva VI, Cerqueira NB, Costa DA, Costa PR, Vasconcelos RP, Madruga VR, Moreira RI, Hoagland B, Veloso VG, Grinsztejn B, Kallás EG; PrEP Brasil Study Team.

AIDS. 2017 Sep 24;31(15):2069-2076. doi: 10.1097/QAD.0000000000001580.

PMID:
28692536
43.

Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study.

Lamas CC, Coelho LE, Grinsztejn BJ, Veloso VG.

Infection. 2017 Dec;45(6):801-809. doi: 10.1007/s15010-017-1041-0. Epub 2017 Jun 28.

44.

Substance use among HIV-infected patients in Rio de Janeiro, Brazil: Agreement between medical records and the ASSIST questionnaire.

Machado IK, Luz PM, Lake JE, Castro R, Velasque L, Clark JL, Veloso VG, Grinsztejn B, De Boni RB.

Drug Alcohol Depend. 2017 Sep 1;178:115-118. doi: 10.1016/j.drugalcdep.2017.04.033. Epub 2017 Jun 16.

45.

Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil.

Martin D, Luz PM, Lake JE, Clark JL, Campos DP, Veloso VG, Moreira RI, Cardoso SW, Klausner JD, Grinsztejn B.

J Int AIDS Soc. 2017 Jun 5;20(1):21405. doi: 10.7448/IAS.20.1.21405.

46.

Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.

da Silva Escada RO, Velasque L, Ribeiro SR, Cardoso SW, Marins LMS, Grinsztejn E, da Silva Lourenço MC, Grinsztejn B, Veloso VG.

BMC Infect Dis. 2017 May 30;17(1):373. doi: 10.1186/s12879-017-2473-y.

47.

Transmitted drug resistance in patients with acute/recent HIV infection in Brazil.

Ferreira ACG, Coelho LE, Grinsztejn E, Jesus CS, Guimarães ML, Veloso VG, Grinsztejn B, Cardoso SW.

Braz J Infect Dis. 2017 Jul - Aug;21(4):396-401. doi: 10.1016/j.bjid.2017.03.013. Epub 2017 May 21.

48.

Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.

de Azevedo SSD, Caetano DG, Côrtes FH, Teixeira SLM, Dos Santos Silva K, Hoagland B, Grinsztejn B, Veloso VG, Morgado MG, Bello G.

Retrovirology. 2017 May 2;14(1):29. doi: 10.1186/s12977-017-0354-5.

49.

High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.

Hoagland B, Moreira RI, De Boni RB, Kallas EG, Madruga JV, Vasconcelos R, Goulart S, Torres TS, Marins LMS, Anderson PL, Luz PM, Costa Leite ID, Liu AY, Veloso VG, Grinsztejn B; PrEP Brasil Study TeamClinical Trial Number 01989611.

J Int AIDS Soc. 2017 Apr 6;20(1):21472. doi: 10.7448/IAS.20.1.21472. Erratum in: J Int AIDS Soc. 2018 Jan 23;21(1):e25069.

50.

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.

Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RD, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Justice AC, Tate JP, Gill J, Pacheco A, Veloso VG, Bucher HC, Egger M, Furrer H, Porter K, Touloumi G, Crane H, Miro JM, Sterne JA, Costagliola D, Saag M, Hernán MA; HIV-CAUSAL Collaboration; Centers for AIDS Research Network of Integrated Clinical Systems.

Lancet HIV. 2017 Jun;4(6):e251-e259. doi: 10.1016/S2352-3018(17)30043-7. Epub 2017 Apr 11.

Supplemental Content

Loading ...
Support Center